New Jefferson CEO Appointed

On behalf of the Board of Trustees, we are thrilled to share the news that after a competitive national search, we have appointed Joseph G. Cacchione, MD as the incoming enterprise-wide CEO of Thomas Jefferson University and Jefferson Health, effective September 6, 2022.

We have found a remarkable leader, and we will be making this announcement today. Dr. Cacchione comes from Ascension Health, one of the largest nonprofit healthcare systems in the U.S., where he has served as an integral leader since 2017. Most recently, Dr. Cacchione served as Executive Vice President, Clinical and Network Services (CNS), for Ascension Health, a $28B organization with 165,000 employees across 145 hospitals and 2,600+ care sites in 19 states and the District of Columbia. Before his current role, he served as CEO of Ascension Michigan with 15 hospitals and 22,000 employees.

While at Ascension, he was instrumental in building the new strategic plan focused on moving to differentiated quality, value, and consumer centricity. He also led Ascension’s enterprise initiative to centralize operations and created an operating company with a common purpose and mission. He has helped develop and launch proprietary accountable care organizations to address the needs of uninsured patients and created multiple programs to help increase health equity.

Joseph G. Cacchione

Joseph G. Cacchione

 Before his time at Ascension Health, Dr. Cacchione spent eight years at the Cleveland Clinic, a leading academic medical center that integrates clinical and hospital care with research and education, where he played a major enterprise role in business development while also serving as Chairman of Operations and Strategy for its Heart and Vascular Institute. And, before that, he spent 20 years as a private practice cardiologist and large private physician practice executive. The depth and breadth of Dr. Cacchione’s previous experience in different markets and business conditions—as well as his demonstrated commitment to DEI both internal to his team and organization and with respect to health and academic equity—make him well-suited to lead Jefferson as it continues to shape the future of healthcare, higher education, and research.

The naming of Dr. Cacchione as the Jefferson enterprise CEO is part of the Board’s development of a new senior executive operating model. Jefferson Health President Bruce A. Meyer, MD, MBA, and Thomas Jefferson University President Mark L. Tykocinski, MD will both report directly to Dr. Cacchione. We believe this new model will further the enterprise mission to improve lives and to reach new heights in higher education, research, and clinical care.

We are grateful to Rich Haverstick for his tireless work as the interim leader of Jefferson since January of this year. Rich has provided the continuity to keep Jefferson moving forward during this time of transition. He has graciously agreed to assist with Dr. Cacchione’s onboarding through December. Chief Human Resource Officer Clayton Fitzhugh has also agreed to lead the transition team for Dr. Cacchione. He will work closely with us, Rich, and Dr. Cacchione to ensure a smooth transition.

We are also grateful to the CEO Search Committee who, together with Egon Zehnder, led this national search and dedicated themselves to identifying and assessing feedback from more than 450 people. This has been the most extensive and inclusive assessment process Jefferson has ever engaged in for a leadership search. We cannot thank them enough for their commitment and thoughtful approach.

The result of this teamwork and collaboration is a CEO who embodies the spirit and mission of Jefferson and will strategically lead us into the future of higher education and healthcare. 

Recent Posts

Prediabetes: The Warning You Don’t Want to Ignore

Prediabetes: The Warning You Don’t Want to Ignore

Prediabetes is one of the most under-recognized and underappreciated health risks we face today. More than one in three adults in the United States meets the criteria for prediabetes, yet the majority are unaware. By definition, it represents blood sugar levels that...

read more
Open Heart Surgery Doesn’t Have to Be Painful

Open Heart Surgery Doesn’t Have to Be Painful

When patients hear they need open heart surgery, the most common reaction is fear, particularly around pain and recovery. The phrase “cracking the chest” has understandably shaped perception, but it does not reflect the modern reality of how thoughtfully a...

read more
AI in Medicine

AI in Medicine

Artificial intelligence is rapidly transforming healthcare — from imaging interpretation to predictive analytics and personalized treatment strategies. Naturally, many patients are asking an important question: “Will AI replace my doctor?” The answer is clear: No. AI...

read more
Beauty of Seasons in Healing

Beauty of Seasons in Healing

There’s something special about a hospital campus that extends beyond the walls where we practice medicine. At Jefferson Einstein Montgomery Hospital, the beauty of our surroundings is not just aesthetic; it’s therapeutic. Whether it’s the reflection of a blue sky...

read more
The Silent Disease Impacting Millions

The Silent Disease Impacting Millions

Type 2 diabetes is often discussed in terms of blood sugar. But in reality, its impact goes far beyond that. From a cardiovascular perspective, it is one of the most powerful drivers of coronary artery disease. It accelerates plaque buildup, increases inflammation,...

read more
You Can Look Healthy and Still Have Heart Disease

You Can Look Healthy and Still Have Heart Disease

You can look perfectly healthy and still have serious heart disease. Here’s why—and what you should do about it.Interested in my book? You can buy it on Amazon! (𝘛𝘩𝘦 𝘷𝘪𝘦𝘸𝘴 𝘦𝘹𝘱𝘳𝘦𝘴𝘴𝘦𝘥 𝘪𝘯 𝘮𝘺 𝘱𝘰𝘴𝘵𝘴 𝘢𝘳𝘦 𝘮𝘺 𝘰𝘸𝘯 𝘢𝘯𝘥 𝘥𝘰 𝘯𝘰𝘵 𝘳𝘦𝘱𝘳𝘦𝘴𝘦𝘯𝘵 𝘵𝘩𝘦 𝘷𝘪𝘦𝘸𝘴 𝘰𝘧 𝘮𝘺 𝘦𝘮𝘱𝘭𝘰𝘺𝘦𝘳 𝘰𝘳 𝘢𝘯𝘺...

read more

Featured

Pages

Questions? Comments?
Reach out to me here:

13 + 10 =

About The Author

Dr. Raymond Singer

Dr. Singer has been in practice since 1992 and has, to date, performed over 8,351 surgeries. His practice interests include complex valve, coronary and aneurysm surgery, as well as prevention and treatment of lung cancer.

2023 Top Doc

2023 Top Doc

TikTok